Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;5(4):42-7.

Prevalence of cryptosporidium infection in immunocompromised patients, in South-west of iran, 2009-10

A Balouty Dehkordy  1 , A Rafiei, Sm Alavi, Sm Latifi
Affiliations

Prevalence of cryptosporidium infection in immunocompromised patients, in South-west of iran, 2009-10

A Balouty Dehkordy et al. Iran J Parasitol. 2010 Dec.

Abstract

Background: Cryptosporidium is a protozoan parasite with worldwide distribution. The aim of this study was to estimate the prevalence of Cryptosporidium infection by antigen detection in faeces among immunocompromised patients referred to educational hospitals of Ahvaz City, South-West of Iran, 2009-2010.

Methods: Fecal samples from 176 immunocompromised patients were collected and Cryptosporidium coproantigen test was performed using ELISA method (DRG kit, Germany). A questionnaire was completed for each case and the results were analyzed using descriptive and Chi-Square tests, by SPSS statistical software (15(th) version).

Results: Our study indicated 5.1% Cryptosporidium infection prevalence in the immunocompromised participated population. Furthermore, 4.2 %, 4 %, 4.5 % and 9.1 % infection rates were identified in children suffered from hematopoietic malignancy, adult cancer patients, renal transplant recipients, and HIV(+) cases, respectively. There was not significant correlation between the infection and age and gender (P>0.05). Infection was most frequent among HIV(+) patients.

Conclusion: The present study confirmed the high prevalence of Cryptosporidium antigen in fecal samples of immunocompromised patients in the region. As no chemotherapeutic agents have yet proven, especially in immunosuppressed patients, therefore our results highlight the importance of preventive intervention in these groups.

Keywords: Coproantigen; Cryptosporidium; ELISA; Immunocompromised patients; Iran; human.

PubMed Disclaimer

References

    1. Gerald DS, Larry SR. Foundations of parasitology. 7th. Mc Graw Hill Companies; 2006. pp. 141–42.
    1. Havelar A, Boonyakarnkul T, Cunliffe D, et al. Guidelines for drinking water qulity, water born pathogens. Geneva: WHO; 2003.
    1. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systemic review and meta analysis. Br J Clin Phamacol. 2007;63(4):387–93. - PMC - PubMed
    1. Paul RH, Gordon N. Epidemiology and clinical features of Cryptosporidium infection in immunocompromise patients. Clin Mic Reviews. 2002;15(1):145–54. - PMC - PubMed
    1. Nahrevanian H, Assmar M. Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran. J Microbiol Immunol Infect. 2008;41:74–77. - PubMed

LinkOut - more resources